Demographics | Data |
---|---|
Age (yr) | 62.7 ± 14.4 |
Sex (men/women) | 31/22 |
Weight (kg) | 81 ± 23 |
Height (cm) | 167 ± 8 |
APACHE II score at admission | 21 ± 5 |
Plasma lactate level at admission (mmol/L) | 1.9 (1.21 to 3.12) |
ICU mortality rate, n (%) | 16 (30%) |
Vasoactive drugs at time of inclusion | |
Norepinephrine, n; dose (μg kg−1 min−1) | 30; 0.19 ± 0.14 |
Dobutamine, n; dose (μg kg−1 min−1) | 13; 5 ± 2 |
Analgesia and sedative drugs | |
Fentanyl, n; dose (μg kg−1 hr−1) | 28; 1.55 ± 0.57 |
Remifentanil, n; dose (μg kg−1 min−1) | 20; 0.14 ± 0.06 |
Midazolam, n; dose (mg kg−1 hr−1) | 32; 0.10 ± 0.04 |
Propofol, n; dose (mg kg−1 hr−1) | 3; 1.25 (1 to 2) |
Morphine, n; dose (mg kg−1 hr−1) | 1; 1.8 |
Ventilator settings | |
Tidal volume (ml/kg predicted body weight) | 8 (6 to 10) |
Respiratory rate (breaths/min) | 19 (18 to 20) |
Total PEEP (cmH2O) | 8 (6 to 10) |
Acute circulatory failure origin, n (%) | |
Postoperative hypovolemia | 7 (13%) |
Hemorrhagic shock | 4 (8%) |
Anoxic encephalopathy | 2 (4%) |
Toxic poisoning | 2 (4%) |
Sepsis/septic shock | 32 (60%) |
Abdominal | 18 |
Pulmonary | 8 |
Urological | 2 |
Neurological | 3 |
Other | 1 |